Aquilo Capital Management’s Genmab GMAB Stock Holding History

Aquilo Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-52,148	Closed	-$1.84M	–	13
2023 Q3	$1.84M	Sell	52,148 -122,500	-70%	-$4.67M	1.67%	9
2023 Q2	$6.64M	Sell	174,648 -68,200	-28%	-$2.72M	3.68%	9
2023 Q1	$9.17M	Hold	242,848	–	–	3.8%	9
2022 Q4	$10.3M	Sell	242,848 -2,000	-0.8%	-$82.4K	3.87%	11
2022 Q3	$7.87M	Buy	244,848 +30,000	+14%	+$1.05M	2.84%	11
2022 Q2	$6.98M	Buy	214,848 +47,348	+28%	+$1.53M	2.38%	11
2022 Q1	$6.06M	Buy	167,500 +40,000	+31%	+$1.37M	0.89%	14
2021 Q4	$5.04M	Hold	127,500	–	–	0.57%	14
2021 Q3	$5.57M	Buy	127,500 +7,500	+6%	+$337K	1.01%	14
2021 Q2	$4.9M	Hold	120,000	–	–	1.27%	15
2021 Q1	$3.94M	Buy	120,000 +30,000	+33%	+$1.13M	0.71%	17
2020 Q4	$3.66M	Buy	90,000 +40,000	+80%	+$1.5M	0.76%	16
2020 Q3	$1.83M	Buy	+50,000	New	+$1.81M	0.19%	17

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aquilo Capital Management's GMAB Position: Q4 2023 in Review

Aquilo Capital Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 52,148 shares — an estimated $1.84M sold.

Aquilo Capital Management first reported a position in GMAB in Q3 2020 and held it in 13 quarters. The position peaked at $10.3M in Q4 2022. 226 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

Aquilo Capital Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
Aquilo Capital Management sold 52,148 Genmab shares in Q4 2023, an estimated $1.84M.
Aquilo Capital Management first reported a position in Genmab in Q3 2020 and held it in 13 quarters.
Aquilo Capital Management's Genmab position peaked at $10.3M in Q4 2022.
226 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Aquilo Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.